Q3 2024 |
182 |
$7.49B |
+$214M |
-$536M |
-$322M |
NVDA, MSFT, GLOB, HEI, RBA
|
13F-HR |
10/15/2024, 02:16 PM |
Q2 2024 |
178 |
$7.36B |
+$424M |
-$545M |
-$121M |
MSFT, NVDA, GLOB, LOPE, HEI
|
13F-HR |
7/17/2024, 02:14 PM |
Q1 2024 |
174 |
$8.2B |
+$172M |
-$481M |
-$309M |
GLOB, MSFT, RBA, MEDP, NVDA
|
13F-HR |
4/26/2024, 04:21 PM |
Q4 2023 |
202 |
$8B |
+$201M |
-$326M |
-$125M |
GLOB, FIVE, LOPE, RBA, MSFT
|
Restatement |
2/15/2024, 02:47 PM |
Q3 2023 |
192 |
$7.33B |
+$268M |
-$424M |
-$156M |
GLOB, RBA, FIVE, LOPE, WK
|
Restatement |
2/15/2024, 02:55 PM |
Q2 2023 |
192 |
$7.93B |
+$779M |
-$501M |
+$277M |
FIVE, GLOB, RBA, CSGP, MSFT
|
13F-HR |
7/25/2023, 01:18 PM |
Q1 2023 |
189 |
$7.13B |
+$234M |
-$463M |
-$229M |
FIVE, RBA, GLOB, LOPE, WK
|
13F-HR |
4/21/2023, 01:45 PM |
Q4 2022 |
195 |
$6.66B |
+$190M |
-$316M |
-$126M |
FIVE, RBA, GLOB, LOPE, CSGP
|
13F-HR |
1/11/2023, 01:04 PM |
Q3 2022 |
194 |
$6.73B |
+$827M |
-$226M |
+$602M |
GLOB, RBA, FIVE, PCTY, CSGP
|
13F-HR |
10/26/2022, 10:27 AM |
Q2 2022 |
195 |
$6.25B |
$0 |
$0 |
|
RBA, GLOB, LOPE, MSFT, FIVE
|
New Holdings |
8/29/2022, 03:02 PM |
Q2 2022 |
199 |
$6.25B |
+$271M |
-$989M |
-$718M |
RBA, GLOB, LOPE, MSFT, FIVE
|
13F-HR |
7/11/2022, 03:47 PM |
Q1 2022 |
161 |
$8.85B |
+$658M |
-$599M |
+$58.9M |
GLOB, AMED, LOPE, RBA, FIVE
|
13F-HR |
4/20/2022, 01:55 PM |
Q4 2021 |
168 |
$10.1B |
+$584M |
-$519M |
+$64.8M |
GLOB, FIVE, WST, RBA, MSFT
|
13F-HR |
1/14/2022, 05:01 PM |
Q3 2021 |
156 |
$9.97B |
+$419M |
-$356M |
+$62.1M |
GLOB, RBA, FIVE, WST, LOPE
|
13F-HR |
10/26/2021, 11:22 AM |
Q2 2021 |
157 |
$9.85B |
+$1.12B |
-$373M |
+$746M |
GLOB, FIVE, RBA, LOPE, AMED
|
13F-HR |
7/26/2021, 01:43 PM |
Q1 2021 |
153 |
$8.78B |
+$632M |
-$714M |
-$82M |
GLOB, LOPE, FIVE, RBA, AMED
|
13F-HR |
4/21/2021, 04:38 PM |
Q4 2020 |
152 |
$9.05B |
+$684M |
-$135M |
+$549M |
GLOB, BL, FIVE, RBA, CSGP
|
13F-HR |
1/22/2021, 04:00 PM |
Q3 2020 |
148 |
$7.17B |
+$568M |
-$312M |
+$257M |
GLOB, RBA, FIVE, PRLB, CSGP
|
13F-HR |
10/8/2020, 01:15 PM |
Q2 2020 |
148 |
$6.37B |
+$324M |
-$247M |
+$77.1M |
GLOB, PRLB, CSGP, LOPE, BL
|
13F-HR |
7/8/2020, 11:53 AM |
Q1 2020 |
137 |
$4.78B |
+$200M |
-$258M |
-$57.9M |
CHE, CSGP, TDOC, LOPE, GLOB
|
13F-HR |
4/13/2020, 03:43 PM |
Q4 2019 |
138 |
$5.57B |
+$183M |
-$269M |
-$86M |
LOPE, CHE, PRLB, CSGP, RBA
|
13F-HR |
1/14/2020, 03:59 PM |
Q3 2019 |
134 |
$5.28B |
+$181M |
-$98.9M |
+$82.2M |
PRLB, CHE, CSGP, RBA, FIVE
|
13F-HR |
10/11/2019, 04:03 PM |
Q2 2019 |
136 |
$5.29B |
+$420M |
-$564M |
-$144M |
PRLB, CSGP, GLOB, LOPE, RBA
|
13F-HR |
7/10/2019, 03:58 PM |
Q1 2019 |
132 |
$5.15B |
+$161M |
-$560M |
-$400M |
ULTI, PRLB, HEI, RBA, LOPE
|
13F-HR |
4/4/2019, 02:56 PM |
Q4 2018 |
131 |
$4.8B |
+$278M |
-$461M |
-$183M |
PRLB, RBA, NATI, HCSG, CHE
|
13F-HR |
1/14/2019, 11:11 AM |
Q3 2018 |
131 |
$5.98B |
+$223M |
-$421M |
-$197M |
PRLB, ULTI, RBA, HEI, CHE
|
13F-HR |
10/3/2018, 12:17 PM |
Q2 2018 |
128 |
$5.55B |
+$252M |
-$403M |
-$150M |
PRLB, FIVE, RBA, CHE, LOPE
|
13F-HR |
7/3/2018, 10:22 AM |
Q1 2018 |
133 |
$5.48B |
+$283M |
-$208M |
+$74.8M |
LOPE, PRLB, NATI, ULTI, HEI
|
13F-HR |
4/3/2018, 11:29 AM |
Q4 2017 |
138 |
$5.17B |
+$159M |
-$360M |
-$201M |
LOPE, PRLB, RBA, ULTI, HCSG
|
13F-HR |
1/24/2018, 02:32 PM |
Q3 2017 |
139 |
$5.08B |
+$214M |
-$437M |
-$223M |
LOPE, CSGP, HCSG, PRLB, NATI
|
13F-HR |
11/1/2017, 12:23 PM |
Q2 2017 |
139 |
$5.23B |
+$382M |
-$456M |
-$73.5M |
NATI, LOPE, CSGP, ULTI, ATHN
|
13F-HR |
7/24/2017, 09:26 AM |
Q1 2017 |
135 |
$4.98B |
+$128M |
-$315M |
-$187M |
LOPE, NATI, ULTI, CSGP, CHE
|
13F-HR |
4/25/2017, 10:01 AM |
Q4 2016 |
133 |
$4.76B |
+$385M |
-$633M |
-$248M |
NATI, LOPE, ULTI, GNTX, CSGP
|
13F-HR |
1/20/2017, 12:47 PM |
Q3 2016 |
131 |
$5B |
+$246M |
-$359M |
-$113M |
CPHD, ULTI, CSGP, NATI, RBA
|
13F-HR |
10/24/2016, 12:33 PM |
Q2 2016 |
133 |
$4.82B |
+$173M |
-$362M |
-$189M |
ULTI, CSGP, RBA, HCSG, ATHN
|
13F-HR |
8/1/2016, 04:53 PM |
Q1 2016 |
135 |
$4.8B |
+$247M |
-$237M |
+$10.8M |
ULTI, CSGP, PRLB, LOPE, ATHN
|
13F-HR |
4/27/2016, 02:41 PM |
Q4 2015 |
138 |
$4.87B |
+$318M |
-$476M |
-$158M |
ULTI, CSGP, ATHN, BECN, CHE
|
13F-HR |
1/28/2016, 05:20 PM |
Q3 2015 |
135 |
$4.85B |
+$337M |
-$424M |
-$86.8M |
ULTI, CPHD, ATHN, CSGP, MD
|
13F-HR |
10/23/2015, 04:00 PM |
Q2 2015 |
134 |
$5.3B |
+$228M |
-$531M |
-$304M |
CPHD, ULTI, TRAK, CSGP, ROL
|
13F-HR |
7/20/2015, 12:06 PM |
Q1 2015 |
131 |
$5.56B |
+$394M |
-$197M |
+$197M |
CPHD, ULTI, CSGP, NATI, GNTX
|
13F-HR |
4/23/2015, 09:39 AM |
Q4 2014 |
129 |
$5.38B |
+$235M |
-$472M |
-$237M |
CPHD, ULTI, RBA, CSGP, ATHN
|
13F-HR |
1/20/2015, 12:43 PM |
Q3 2014 |
128 |
$5.13B |
+$377M |
-$711M |
-$335M |
CPHD, ULTI, NATI, ATHN, RBA
|
13F-HR |
11/5/2014, 12:31 PM |
Q2 2014 |
130 |
$5.74B |
+$413M |
-$60.5M |
+$352M |
CPHD, ULTI, NATI, PRAA, RBA
|
13F-HR |
7/31/2014, 11:47 AM |
Q1 2014 |
128 |
$5.53B |
+$250M |
-$178M |
+$71.9M |
CPHD, ULTI, PRAA, RBA, MD
|
13F-HR |
5/9/2014, 12:10 PM |
Q4 2013 |
126 |
$5.52B |
$0 |
$0 |
|
CPHD, ULTI, NATI, CSGP, ATHN
|
13F-HR |
2/10/2014, 10:41 AM |